comparemela.com

Latest Breaking News On - சுமிட் அகர்வால் - Page 4 : comparemela.com

Sonu Sood asks doctors to prescribe substitutes for unavailable COVID 19 medicines; Fans agree with him

Sonu Sood asks doctors to prescribe substitutes for unavailable COVID 19 medicines; Fans agree with him
pinkvilla.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from pinkvilla.com Daily Mail and Mail on Sunday newspapers.

Drunk businessman s car mows down ragpicker, injures police constable

Drunk businessman’s car mows down ragpicker, injures police constable Accident exposes violation of govt’s Covid directives; police issue fresh order An alleged drunken brawl in a bar spilled onto the road when a BMW of one of the groups hit an Audi of the other and several stationary vehicles before killing a ragpicker early on Friday. The accident happened in front of Singhji’s Bar cum Restaurant on Rajdanga Main Road, not far from the Ruby crossing. The bar-cum-restaurant was operating illegally in the heart of the city, in violation of government directives. The state government has announced the closure of bars and restaurants to curb the spread of Covid-19 in the state,  violation of which attracts penal sections under the disaster management act.

Nazara and Metropolis release revenue numbers before board approval

Nazara, Metro Health’s earnings announcements before board approval raise eyebrows SECTIONS Share Synopsis The move has raises eyebrows among some market participants, who allege the companies may have violated rules. Agencies Related NSE Metropolis Healthcare divulged some of their earnings numbers to stock exchanges even before making the mandatory announcement of a board meeting date to approve the results. The move has raises eyebrows among some market participants, who allege the companies may have violated rules. In a business update for FY21 filed with stock exchanges, newly listed Nazara Technologies said that the company delivered unaudited consolidated revenue of Rs 454 crore in FY21 which is 84% growth over FY20 figure of Rs 247.5 crore. It also said that EBITDA (earnings before interest, taxes, depreciation, and amortization) including share of non-controlling interest for FY21 has witnessed 470% growth over FY20.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.